A pilot study of tumor-derived exosomes as diagnostic and prognostic markers in breast cancer patients receiving neoadjuvant chemotherapy.
R. Raab(Medizinische Hochschule Hannover), Adam S. Asch(Cornell University), Traci Pawlowski(Illumina (United States)), Michael Klass, J. H. Wong, David Spetzler(Caris Life Sciences (United States)), Lisa Bellin, Christine Kuslich(Phoenix (United States))
Cited by 3
Related Papers
Changes in circulating microRNA levels associated with prostate cancer
|British Journal of Cancer|2012|717
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
|Cancer Cell|2021|453
Identification of genetic variants using bar-coded multiplexed sequencing
|Nature Methods|2008|305
Recurrence Patterns of Hepatocellular and Fibrolamellar Carcinoma After Liver Transplantation
|Journal of Clinical Oncology|1999|216